What Can We Expect From Becton Dickinson (NYSE:BDX) After Evercore ISI’s Latest Coverage?

April 23, 2018 - By Kurt Siggers

Becton, Dickinson and Company (NYSE:BDX) Logo

Investors sentiment increased to 1.55 in Q4 2017. Its up 0.62, from 0.93 in 2017Q3. It improved, as 50 investors sold Becton, Dickinson and Company shares while 294 reduced holdings. 147 funds opened positions while 386 raised stakes. 215.77 million shares or 9.23% more from 197.53 million shares in 2017Q3 were reported.

2.01 million were reported by Natl Bank Of New York Mellon. The New York-based Gabelli Funds Ltd Liability Corporation has invested 0.11% in Becton, Dickinson and Company (NYSE:BDX). Moreover, Arrowstreet Limited Partnership has 0.01% invested in Becton, Dickinson and Company (NYSE:BDX). Gotham Asset Ltd Limited Liability Company reported 0.01% in Becton, Dickinson and Company (NYSE:BDX). Beese Fulmer Invest Management holds 1.31% or 28,462 shares. 7,084 were reported by Trustmark Comml Bank Trust Department. Livforsakringsbolaget Skandia Omsesidigt reported 3,499 shares. Macquarie Grp Inc Limited holds 99,767 shares or 0.04% of its portfolio. 1,632 are held by Dorsey And Whitney Trust. Natl Bank Of Nova Scotia invested in 0.02% or 1,054 shares. Parallax Volatility Advisers L P owns 6,193 shares. 12,585 are held by Glg Limited Liability Company. Moreover, Tradewinds Mngmt Lc has 0.01% invested in Becton, Dickinson and Company (NYSE:BDX) for 64 shares. 49,483 are owned by Northwestern Mutual Wealth Mngmt Communication. Acadian Asset Management invested 0% in Becton, Dickinson and Company (NYSE:BDX).

Since February 23, 2018, it had 0 buys, and 4 insider sales for $2.59 million activity. Gallagher John E also sold $1.21M worth of Becton, Dickinson and Company (NYSE:BDX) shares. Shares for $426,079 were sold by Polen Thomas E Jr. Borzi James W sold $910,726 worth of Becton, Dickinson and Company (NYSE:BDX) on Monday, February 26.

Why Has Evercore ISI Given Becton Dickinson (NYSE:BDX) a $245.0 Price Target

Evercore ISI has just issued a Buy rating for Becton Dickinson (NYSE:BDX) shares. The firm has begun coverage on shares of BDX in a research report sent to investors on 3 January. This price target indicates upside of 5.11 % from the last close price of Becton Dickinson (NYSE:BDX).

Investors sentiment increased to 1.55 in Q4 2017. Its up 0.62, from 0.93 in 2017Q3. It improved, as 50 investors sold Becton, Dickinson and Company shares while 294 reduced holdings. 147 funds opened positions while 386 raised stakes. 215.77 million shares or 9.23% more from 197.53 million shares in 2017Q3 were reported.

2.01 million were reported by Natl Bank Of New York Mellon. The New York-based Gabelli Funds Ltd Liability Corporation has invested 0.11% in Becton, Dickinson and Company (NYSE:BDX). Moreover, Arrowstreet Limited Partnership has 0.01% invested in Becton, Dickinson and Company (NYSE:BDX). Gotham Asset Ltd Limited Liability Company reported 0.01% in Becton, Dickinson and Company (NYSE:BDX). Beese Fulmer Invest Management holds 1.31% or 28,462 shares. 7,084 were reported by Trustmark Comml Bank Trust Department. Livforsakringsbolaget Skandia Omsesidigt reported 3,499 shares. Macquarie Grp Inc Limited holds 99,767 shares or 0.04% of its portfolio. 1,632 are held by Dorsey And Whitney Trust. Natl Bank Of Nova Scotia invested in 0.02% or 1,054 shares. Parallax Volatility Advisers L P owns 6,193 shares. 12,585 are held by Glg Limited Liability Company. Moreover, Tradewinds Mngmt Lc has 0.01% invested in Becton, Dickinson and Company (NYSE:BDX) for 64 shares. 49,483 are owned by Northwestern Mutual Wealth Mngmt Communication. Acadian Asset Management invested 0% in Becton, Dickinson and Company (NYSE:BDX).

Since February 23, 2018, it had 0 buys, and 4 insider sales for $2.59 million activity. Gallagher John E also sold $1.21M worth of Becton, Dickinson and Company (NYSE:BDX) shares. Shares for $426,079 were sold by Polen Thomas E Jr. Borzi James W sold $910,726 worth of Becton, Dickinson and Company (NYSE:BDX) on Monday, February 26.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

Among 14 analysts covering Becton (NYSE:BDX), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Becton has $260.0 highest and $230.0 lowest target. $249.64’s average target is 7.10% above currents $233.09 stock price. Becton had 18 analyst reports since October 24, 2017 according to SRatingsIntel. The stock of Becton, Dickinson and Company (NYSE:BDX) earned “Hold” rating by Citigroup on Friday, January 5. The firm has “Hold” rating by RBC Capital Markets given on Friday, November 3. The stock of Becton, Dickinson and Company (NYSE:BDX) earned “Buy” rating by Stifel Nicolaus on Thursday, November 2. The stock of Becton, Dickinson and Company (NYSE:BDX) earned “Outperform” rating by Wells Fargo on Tuesday, October 24. Citigroup upgraded Becton, Dickinson and Company (NYSE:BDX) on Tuesday, April 10 to “Buy” rating. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, November 3. Piper Jaffray maintained the shares of BDX in report on Tuesday, February 6 with “Buy” rating. The stock of Becton, Dickinson and Company (NYSE:BDX) earned “Buy” rating by Deutsche Bank on Friday, December 29. As per Tuesday, February 6, the company rating was maintained by Jefferies. Jefferies maintained Becton, Dickinson and Company (NYSE:BDX) on Thursday, November 9 with “Buy” rating.

The stock increased 0.09% or $0.21 during the last trading session, reaching $233.09. About 279,356 shares traded. Becton, Dickinson and Company (NYSE:BDX) has risen 15.92% since April 23, 2017 and is uptrending. It has outperformed by 4.37% the S&P500.

Analysts await Becton, Dickinson and Company (NYSE:BDX) to report earnings on May, 3 before the open. They expect $2.61 earnings per share, up 13.48 % or $0.31 from last year’s $2.3 per share. BDX’s profit will be $694.89 million for 22.33 P/E if the $2.61 EPS becomes a reality. After $2.48 actual earnings per share reported by Becton, Dickinson and Company for the previous quarter, Wall Street now forecasts 5.24 % EPS growth.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company has market cap of $62.06 billion. It operates in two divisions, BD Medical and BD Life Sciences. It has a 180.97 P/E ratio. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

Becton, Dickinson and Company (NYSE:BDX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.